Thursday, October 31, 2024

3:35 PM - 4:20 PM

---

Details

This panel discussion will focus on the state of the art and current trends in the field of iPSC-derived cell therapies in terms of their potential, diversity, progress, and key challenges. Scientific, manufacturing, quality, regulatory, and economic parameters will be discussed in the context of other cell therapies and biologics. The panel will touch on emerging technologies such as modified / armoured cell therapies derived from iPSCs and on the range of new functionalities and features that these technologies confer. The purpose of this session is to show that iPSCs are unfolding their potential in specific areas and that new technology can help iPSC-derived therapies become relevant in large disease indications.

---

Speaker